Hospital News and Research

RSS

ACO's raise hope but also questions

The Wall Street Journal: "Spurred by incentives in the federal health-overhaul law, hospitals and doctors around the country are beginning to create new entities that aim to provide more efficient health care," called ACO's. "But these efforts are already raising questions about whether they can truly save money, or if they might actually drive costs higher. In Arizona, Tucson Medical Center is forming a company that the hospital will own jointly with local physicians' practices.

29 Nov 2010

Wolters Kluwer Health subsidiary to acquire Pharmacy OneSource

Wolters Kluwer Health today announced that one of its wholly- owned subsidiaries has entered into an agreement to acquire Pharmacy OneSource, a leading healthcare Software-as-a-Service (SaaS) provider that helps hospitals manage the complex challenges of patient safety, compliance and efficiency. The transaction will allow Wolters Kluwer Health to extend its Clinical Decision Support (CDS) solutions into the hospital pharmacy market and will further strengthen the company's leadership position in the growing point-of-care market.

29 Nov 2010

FDA approves Merit's phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere Microspheres

The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.

29 Nov 2010

IMRISneuro sold to Dartmouth-Hitchcock Medical Center

IMRIS Inc. today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire.

29 Nov 2010

DR Systems ranked leading PACS vendor for large hospitals

DR Systems, one of the most respected names in healthcare information systems, has been recognized by KLAS as the leading PACS vendor for large hospitals.

29 Nov 2010

Ziosoft announces launch of PhyZiodynamic solutions at RSNA 2010

Ziosoft, Inc., a leader in functional visualization and analytics, will launch its PhyZiodynamic solutions at the Radiology Society of North America (RSNA) being held November 28 – December 3, 2010 in Chicago. PhyZiodynamic solutions represent a generational leap in advanced visualization.

29 Nov 2010

DICOM Grid releases ImageCare scalable cloud computing platform for medical imaging management

DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.

29 Nov 2010

Genesis deploys BIO-key's finger-based biometric identification solutions

BIO-key International, Inc., a leader in finger-based biometric identification solutions, announced the successful deployment by Genesis HealthCare System, based in Zanesville, Ohio, of BIO-key's biometric identification for staff to quickly, conveniently and securely establish their identity when ordering, verifying or administering medications as required by Ohio law.

29 Nov 2010

Positive results from Oncolytics' combination REOLYSIN-docetaxel Phase I trial in advanced cancer

Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).

29 Nov 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

3SBio acquires pegsiticase global rights from EnzymeRx for $6.25 million

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced that is has acquired worldwide rights of pegsiticase for all indications from EnzymeRx for a total consideration of US$6.25 million.

29 Nov 2010

DePuy Spine, Lanx, Medtronic, Zimmer Spine and Codman support NREF's post-residency clinical fellowships

The NREF has reached agreements with Medtronic, Lanx and Zimmer Spine to provide funding to the NREF in support of the Foundation's post-residency clinical fellowship grant program. The NREF is pleased to report that it has renewed its agreements with Codman & Shurtleff, Inc. and DePuy Spine, Inc., who supported the inaugural year of the fellowship program in 2010.

29 Nov 2010

Toshiba to showcase episode-based care solutions at RSNA annual meeting

Containing costs while delivering high-quality, effective care is a directive of healthcare reform. With episode-based care as part of the reform mandate, many healthcare providers are uncertain about its effect on both patient outcomes and their bottom-line. Toshiba America Medical Systems, Inc. is partnering with leading healthcare providers to develop solutions to address episode-based care by effectively utilizing patient-focused imaging technology and a multidisciplinary collaborative approach to treatment.

29 Nov 2010

NovaBay announces meeting with FDA to discuss Aganocide compound for impetigo

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.

29 Nov 2010

Baylor Health Care System receives $20 million to benefit transplantation initiatives

Baylor Health Care System Foundation announces that Annette C. and Harold C. Simmons have pledged $20 million to benefit transplantation initiatives within Baylor Health Care System. In recognition of this transformational gift, Baylor will rename the institute the Annette C. and Harold C. Simmons Transplant Institute.

29 Nov 2010

Golden Valley acquires Digit-Pro and Cut Stop

Golden Valley Development, Inc. is pleased to announce that it has recently completed the acquisition of two new companies, each having a licensing agreement to manufacture and market a new patented technology.

29 Nov 2010

Study finds association between DGKK gene and hypospadias

Hypospadias is a common congenital malformation of the male external genitalia, affecting 1 in 375 boys. In hypospadias patients, the urethral opening is not located at the tip of the penis, but somewhere halfway, at the base of the penis, or even in the scrotum.

29 Nov 2010

Study reports increased CT usage in emergency departments

A new study reports that the use of computed tomography (CT) in the nation's emergency departments is growing exponentially. If the growth trend continues, by 2011, nearly 20 percent of all emergency department (ED) visits may involve a CT exam. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA) and published online and in the journal Radiology.

29 Nov 2010

Researchers identify effects of endurance running

Using a mobile MRI unit, researchers followed runners for two months along a 4,500-kilometer course to study how their bodies responded to the high-stress conditions of an ultra-long-distance race, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2010

Jefferson Hospital offers shortest wait times for patients seeking kidney transplant: SRTR

A recent listing of Philadelphia adult kidney transplant programs by The Scientific Registry of Transplant Recipients (SRTR) has listed the transplant program at Thomas Jefferson University Hospital as having the shortest wait times for patients seeking a transplant among programs that have a three-year survival rate of greater than 90 percent.

29 Nov 2010